SUMMIT THERAPEUTICS - PHASE II STUDY EVALUATES IVONESCIMAB ALONE AND WITH CADONILIMAB OR IPILIMUMAB IN ADVANCED CCRCC

Reuters · 2d ago

Please log in to view news